Protagen AG and MicroDiscovery GmbH cooperate in biomarker development
„Our proprietary technology platform UNIarray® and MicroDiscovery’s certified software solutions for the analysis of complex marker panels complement each other perfectly,“ states Dr. Peter Schulz-Knappe, CSO and Executive Vice President Diagnostics of Protagen AG and adds: „The cooperation strengthens our position in biomarker development and supports the efficient development of marketable products.”
Dr. Arif Malik, CEO of MicroDiscovery GmbH, confirms: „Our experience in analyzing clinical studies for multiplex assays and array data perfectly fits with Protagen’s established screening platform. This illustrates the value of MicroDiscovery’s bioinformatics methods and software solutions for the development of new diagnostics.”
Organizations
Other news from the department business & finance
These products might interest you
Limsophy by AAC Infotray
Optimise your laboratory processes with Limsophy LIMS
Seamless integration and process optimisation in laboratory data management
ERP-Software GUS-OS Suite by GUS
Holistic ERP solution for companies in the process industry
Integrate all departments for seamless collaboration
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.